ADVENTRX Pharmaceuticals (ANX) Swings to Q2 Profit
Tweet
Share
E-mailGet Alerts ANX Hot Sheet
Price: $0.73 --0%
Financial Fact:
Net loss per common share - basic and diluted: -0.04
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss per common share - basic and diluted: -0.04
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q2 EPS of $0.09, versus ($0.17) reported last year.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- Royal Unibrew reports higher interim first-half profit as margins improve
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
